Schrödinger

Schrödinger, Inc. is a company that uses computational platforms to discover novel molecules for drug development and materials design. Their software is licensed globally and they also leverage it for internal drug discovery programs. Schrödinger is currently advancing three clinical-stage oncology programs.

Funding Round: Grant

Funding Amount: $9.5M

Date: 18-Nov-2024

Investors: Bill & Melinda Gates Foundation

Markets: Pharmaceuticals, Biotechnology, Drug Discovery, Computational Chemistry, Software Development

HQ: New York, New York, United States

Founded: 1990

Website: https://www.schrodinger.com/

LinkedIn: https://www.linkedin.com/company/schr-dinger

Twitter:

Instagram: https://www.instagram.com/schrodinger.inc/?hl=en

Facebook:

Crunchbase: https://www.crunchbase.com/organization/schrodinger?utm_source=linkedin&utm_medium=referral&utm_campaign=linkedin_companies&utm_content=profile_cta_anon&trk=funding_crunchbase

Pitchbook:


Similar Startups


Leave a Comment

    🔷 Buy VC Database 🟩 Buy Startup Database 🎁 Get Free Sample

    Share this: